Mme Docteur Célia DELPECH
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Localisation des cabinets
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
DOCTEUR DIARRA MOUSSA
1 PLACE SAINT LEONARD, 91100 Corbeil-Essonnes
Libéral© OpenStreetMapCABINET DU DR Celia DELPECH
HOPITAL PRIVE CLAUDE GALIEN — 20 ROUTE DE BOUSSY SAINT ANTOINE, 91480 Quincy-sous-Sénart
Libéral© OpenStreetMap
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials
Journal of clinical medicine · 2022
Lire l'abstract Crossref ↓
Objective: Update the available evidence comparing biologic disease-modifying antirheumatic drugs (bDMARDs) in combination with conventional synthetic disease-modifying antirheumatic drugs (CsDMARDs) to bDMARDs in monotherapy in patients with rheumatoid arthritis. Methods: Research was limited to randomized controlled trials. Major outcome: ACR 20 response criteria at 24 weeks. Secondary outcomes: clinical and radiographic criteria at week 24, 52 and 104. Results: 23 trials (6358 patients), including seven bDMARDs and one other molecule: Anbainuo (anti-TNF-R). No study satisfied our search criteria for anakinra, certolizumab and infliximab. Compared to bDMARD monotherapy, combination therapy gives a better ACR 20 at 24 weeks (RR: 0.88 (0.84–0.94)) in fixed and random effect models, and this result is sustained at 52 and 104 weeks. The results were mostly similar for all other outcomes without increasing the risk of adverse effects. Conclusion: This meta-analysis confirms the superiority of combination therapy over monotherapy in rheumatoid arthritis, in accordance to the usual guidelines.
Publications scientifiques (1) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Essai clinique1
▼
Essai clinique1
▼- Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials
Journal of clinical medicine · 2022 · Journal Article
Delpech C, Laborne FX, Hilliquin P
📚 8 cit.🔬→🩺 Translationnel
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials
Journal of clinical medicine · 2022 · Journal Article
Delpech C, Laborne FX, Hilliquin P
📚 8 cit.🔬→🩺 Translationnel
Revue générale1
▼
Revue générale1
▼- Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials
Journal of clinical medicine · 2022 · Journal Article
Delpech C, Laborne FX, Hilliquin P
📚 8 cit.🔬→🩺 Translationnel
